154 related articles for article (PubMed ID: 37225627)
1. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors.
Sarac E; Demirkesen C
An Bras Dermatol; 2023; 98(5):720-722. PubMed ID: 37225627
[No Abstract] [Full Text] [Related]
2. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman.
Leeolou MC; Young PA; Saleem A; Narala S; Bae GH
Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809093
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
Salah E
J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
[TBL] [Abstract][Full Text] [Related]
4. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Valentim FO; Oliveira CC; Miot HA
An Bras Dermatol; 2019; 94(1):99-101. PubMed ID: 30726474
[TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
Bakr F; Wain EM; Barlow R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
[TBL] [Abstract][Full Text] [Related]
6. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
7. CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Richter J; Oschlies I; Kock K; Wüseke T; Haag J; Koch K; Klapper W
J Pathol; 2024 Feb; 262(2):189-197. PubMed ID: 37933684
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.
Plumptre IR; Said JT; Sun T; Larocca C; Virgen CA; Kupper TS; Fisher DC; Devlin PM; Elco CP; Song JS; LeBoeuf NR
Leuk Lymphoma; 2022 Dec; 63(12):2832-2846. PubMed ID: 35862569
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature.
Keeling BH; Gavino ACP; Admirand J; Soldano AC
J Cutan Pathol; 2017 Nov; 44(11):944-947. PubMed ID: 28749588
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous CD4
Plumptre IR; Said JT; Sheu Song J; Corey K; LeBoeuf NR
Pediatr Blood Cancer; 2022 Sep; 69(9):e29862. PubMed ID: 35730956
[TBL] [Abstract][Full Text] [Related]
11. Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Mimicking Jessner Lymphocytic Infiltrate and Tumid Lupus-A Report of Two Cases.
Yi LG; Gru AA
Am J Dermatopathol; 2021 Dec; 43(12):e293-e297. PubMed ID: 34001748
[TBL] [Abstract][Full Text] [Related]
12. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series.
Surmanowicz P; Doherty S; Sivanand A; Parvinnejad N; Deschenes J; Schneider M; Hardin J; Gniadecki R
Dermatology; 2021; 237(4):618-628. PubMed ID: 33326960
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous small/medium CD4
Xu J; Huang Q
Blood; 2018 Aug; 132(7):765. PubMed ID: 30115635
[No Abstract] [Full Text] [Related]
15. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
[TBL] [Abstract][Full Text] [Related]
16. Two women with primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder during pregnancy.
Gambichler T; Scheel CH; Kock K; Klapper W; Doerler M; Boms S
Clin Exp Dermatol; 2023 Apr; 48(5):533-535. PubMed ID: 36763762
[No Abstract] [Full Text] [Related]
17. Adnexotropism as a Histopathological Clue for the Diagnosis of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder.
Pérez González YC; Llamas Velasco MDM; Díaz Recuero JL; Machan S; Núñez Hipolito L; Piris Pinilla MA; Rodríguez Pinilla SM
Am J Dermatopathol; 2020 May; 42(5):383-384. PubMed ID: 31313694
[No Abstract] [Full Text] [Related]
18. Cutaneous T-cell lymphoproliferative disorders: approach for the surgical pathologist: recent advances and clarification of confused issues.
Liu V; McKee PH
Adv Anat Pathol; 2002 Mar; 9(2):79-100. PubMed ID: 11917163
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound findings in case series of patients with primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Recio-Monescillo M; Mendoza-Cembranos MD; Torre-Castro J; Moya-Martínez C; Ruffin-Vicente B; Díaz-Recuero JL; Córdoba R; López-Robles J; Pelayo I; Rodríguez-Pinilla M; Requena L
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):e320-e322. PubMed ID: 37907275
[No Abstract] [Full Text] [Related]
20. Dermoscopy of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Rodríguez-Lomba E; Lobato-Berezo A; Pulido-Pérez A; Parra-Blanco V; Avilés-Izquierdo JA
Int J Dermatol; 2020 Jun; 59(6):755-757. PubMed ID: 32010958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
